Search Results - "Félicie Chaumont"

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial by Pannus, Pieter, Depickère, Stéphanie, Kemlin, Delphine, Houben, Sarah, Neven, Kristof Y, Heyndrickx, Leo, Michiels, Johan, Willems, Elisabeth, De Craeye, Stéphane, Francotte, Antoine, Chaumont, Félicie, Olislagers, Véronique, Waegemans, Alexandra, Verbrugghe, Mathieu, Schmickler, Marie-Noëlle, Van Gucht, Steven, Dierick, Katelijne, Marchant, Arnaud, Desombere, Isabelle, Ariën, Kevin K, Goossens, Maria E

“…Fractional dosing of COVID-19 vaccines could accelerate vaccination rates in low-income countries. Dose-finding studies of the mRNA vaccine BNT162b2…”
Get full text

Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults by Pannus, Pieter, Depickère, Stéphanie, Kemlin, Delphine, Georges, Daphnée, Houben, Sarah, Olislagers, Véronique, Waegemans, Alexandra, De Craeye, Stéphane, Francotte, Antoine, Chaumont, Félicie, Van Oostveldt, Celien, Heyndrickx, Leo, Michiels, Johan, Willems, Elisabeth, Dhondt, Emilie, Krauchuk, Marharyta, Schmickler, Marie-Noëlle, Verbrugghe, Mathieu, Van Loon, Nele, Dierick, Katelijne, Matagne, André, Desombere, Isabelle, Ariën, Kevin K., Marchant, Arnaud, Goossens, Maria E.

“…Nursing home residents, a frail and old population group, respond poorly to primary mRNA COVID-19 vaccination. A third dose has been shown to boost protection…”
Get full text

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y. Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K. Ariën, Maria E. Goossens

“…Fractional dosing of COVID-19 vaccines could accelerate vaccination rates in low-income countries. Dose-finding studies of the mRNA vaccine BNT162b2…”
Get full text